Barinthus Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	106.1	142.09	194.39	214.05	43.27	11.43
Cash & Short-Term Investments	106.1	142.09	194.39	214.05	43.27	11.43
Cash Growth	-33.81%	-26.90%	-9.19%	394.74%	278.46%	-
Accounts Receivable	14.97	-	5.85	0.02	0.52	0.99
Other Receivables	6.06	7.94	6.31	6.93	3.01	2.92
Receivables	21.02	7.94	12.16	6.95	3.53	3.91
Prepaid Expenses	7.06	5.4	5.89	4.61	1.08	0.91
Other Current Assets	0.46	1.47	0.61	1.15	0.03	-
Total Current Assets	134.65	156.91	213.04	226.77	47.9	16.25
Property, Plant & Equipment	18.16	19.4	15.71	9.09	2.77	2.79
Goodwill	12.21	12.21	12.21	12.63	-	-
Other Intangible Assets	22.74	25.11	28.27	31.43	-	-
Other Long-Term Assets	0.93	0.88	0.98	0.8	-	-
Total Assets	188.69	214.51	270.21	280.72	50.67	19.04
Accounts Payable	3.08	1.6	3.75	2.42	4.67	3.89
Accrued Expenses	7.97	9.21	8.06	7.88	2.54	1.42
Short-Term Debt	-	-	-	0.16	-	-
Current Portion of Leases	1.99	1.79	0.43	0.52	0.19	0.17
Current Unearned Revenue	2.04	-	-	0.18	0.25	0.27
Total Current Liabilities	15.07	12.6	12.24	11.16	7.64	5.75
Long-Term Debt	-	-	-	-	44.7	-
Long-Term Leases	10.68	11.19	8.34	6.54	1.47	1.61
Long-Term Deferred Tax Liabilities	0.46	0.57	3.75	8.08	-	-
Other Long-Term Liabilities	3.02	3.15	2.68	2.37	-	-
Total Liabilities	29.23	27.51	27	28.15	53.81	7.36
Common Stock	0	0	0	0	-	0
Additional Paid-In Capital	391.88	386.6	379.5	369.1	21.66	15.91
Retained Earnings	-217.12	-176.59	-103.24	-108.59	-57.72	-37.89
Comprehensive Income & Other	-15.47	-23.23	-33.37	-8.39	-1.24	-0.47
Total Common Equity	159.29	186.78	242.9	252.13	-37.3	-22.45
Minority Interest	0.17	0.21	0.31	0.44	0.39	0.37
Shareholders' Equity	159.46	187	243.2	252.56	-3.15	11.69
Total Liabilities & Equity	188.69	214.51	270.21	280.72	50.67	19.04
Total Debt	12.67	12.98	8.77	7.22	46.36	1.78
Net Cash (Debt)	93.43	129.11	185.61	206.83	-3.1	9.65
Net Cash Growth	-36.70%	-30.44%	-10.26%	-	-	-
Net Cash Per Share	2.40	3.36	4.86	7.99	-0.39	411.37
Filing Date Shares Outstanding	40.23	38.92	38.34	37.19	0.03	0.02
Total Common Shares Outstanding	39.54	38.64	37.68	37.19	0.03	0.02
Working Capital	119.58	144.31	200.8	215.61	40.26	10.5
Book Value Per Share	4.03	4.83	6.45	6.78	-1447.99	-953.22
Tangible Book Value	124.35	149.47	202.42	208.07	-37.3	-22.45
Tangible Book Value Per Share	3.14	3.87	5.37	5.59	-1447.99	-953.22
Machinery	-	6.84	5.35	2.09	1.06	0.77
Leasehold Improvements	-	8.67	3.93	0.63	0.05	-

Source: S&P Capital IQ. Standard template. Financial Sources.